Abstract (EN):
Streptococcus agalactiae (group B streptococcus [GBS]) is the leading cause of neonatal pneumonia, sepsis,
and meningitis. An in silico genome analysis indicated that GBS strain NEM316 encodes 35 proteins containing
an LPXTG motif which are thought to be covalently linked to the peptidoglycan by an enzyme called
sortase. The role of these cell wall-anchored proteins in GBS pathogenesis was evaluated on a global level by
inactivating the srtA gene. This gene encodes the major sortase SrtA that anchors most of the LPXTGcontaining
proteins. We chose the C5a peptidase (ScpB) and Alp2, an abundant immunogenic protein, as
prototypical LPXTG-containing proteins. As expected, the SrtA knockout mutant was unable to anchor the C5a
peptidase (ScpB) and Alp2 to the cell wall. Complementation with plasmid-borne srtA inserted into the
chromosome restored the correct surface localization of both ScpB and Alp2. Interestingly, the SrtA mutant
was impaired for binding to the major extracellular matrix components fibronectin and fibrinogen and
displayed a significant reduction in adherence to human (A549, HeLa, and Caco-2) and murine (L2) epithelial
cells compared to the parental wild-type strain. Surprisingly, the inactivation of srtA had no effect on the
virulence of the type III strain of GBS in a neonatal rat model (measured by the 50% lethal dose and lung
colonization) but strongly impaired the capacity of the strain to colonize the intestines of gnotobiotic mice in
a competition assay. These results demonstrate that LPXTG-containing proteins are involved in cell adhesion
and GBS persistence in vivo.
Language:
Portuguese
Type (Professor's evaluation):
Scientific
License type: